GO:0046381 CMP-N-acetylneuraminate metabolic process: Sialic Acid Activation Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0046381 describes the chemical reactions and pathways involving CMP-N-acetylneuraminate, the activated nucleotide-sugar donor used by sialyltransferases for sialylation of glycoproteins and glycolipids.
• CMP-N-acetylneuraminate is formed by CMP-N-acetylneuraminate synthetase, which couples N-acetylneuraminate to CMP; the Vibrio cholerae enzyme structure has been solved, revealing conserved catalytic features.
• The pathway supplies sialyltransferase substrates; human cervical epithelium sialyltransferase uses CMP-N-acetylneuraminate to sialylate galactosyl-glycoproteins.
• Downstream sialylation influences host-commensal homeostasis in the intestine, where mucus sialylation is a key determinant.
• In vertebrates, alpha2,8-sialyltransferases (ST8Sia family) consume CMP-N-acetylneuraminate to build polysialic acid, affecting infection and neural biology.
• CMP-N-acetylneuraminate can be further modified, for example by hydroxylase or monooxygenase activities that alter the N-acyl group, as shown in mouse liver and starfish.
Description
CMP-N-acetylneuraminate metabolic process (GO:0046381) is the biological process encompassing the chemical reactions and pathways involving CMP-N-acetylneuraminate, a nucleotide-sugar composed of N-acetylneuraminic acid in glycosidic linkage with cytidine monophosphate. This metabolite is the universal activated donor for sialyltransferases, the enzymes that transfer sialic acid to glycoconjugates. The pathway is therefore central to the biosynthesis of sialylated glycoproteins and glycolipids in animals and in some bacteria. Researchers study GO:0046381 because its output, CMP-N-acetylneuraminate, controls the availability of sialic acid for cell-surface and secreted glycans, which in turn regulate cell recognition, signaling, and host-microbe interactions. The process is not limited to mammals: bacterial CMP-N-acetylneuraminate synthetases, such as that from Vibrio cholerae, have been structurally and functionally characterized, highlighting the evolutionary conservation of this activation step. In vertebrates, the pathway feeds alpha2,8-sialyltransferases (ST8Sia enzymes) that produce polysialic acid on neural cell adhesion molecules and other acceptors. Perturbations in sialylation have been linked to infection outcomes, immune regulation, and cancer-associated antigen expression, making GO:0046381 a relevant node for both basic glycobiology and translational research.
CMP-N-acetylneuraminate metabolic process At A Glance
| GO ID | GO:0046381 |
|---|---|
| GO term | CMP-N-acetylneuraminate metabolic process |
| Ontology | biological_process |
| Synonym | CMP-N-acetylneuraminate metabolism |
| Definition | The chemical reactions and pathways involving CMP-N-acetylneuraminate, a substance composed of 5-(acetylamino)-3,5-dideoxy-D-glycero-D-galacto-non-3-ulosonic acid in glycosidic linkage with cytidine monophosphate. |
| Major function | Production and utilization of the activated sialic acid donor CMP-N-acetylneuraminate for sialylation of glycoproteins and glycolipids. |
| Key enzyme | CMP-N-acetylneuraminate synthetase, structurally characterized from Vibrio cholerae. |
| Downstream consumers | Sialyltransferases including alpha2,8-sialyltransferases (ST8Sia family) in vertebrates. |
| Related modification | CMP-N-acetylneuraminate hydroxylase / monooxygenase activities that modify the N-acyl group. |
What Is GO:0046381?
In simple terms, GO:0046381 covers the making, modification, and use of CMP-N-acetylneuraminate, the activated form of sialic acid. Formally, it is the biological process comprising the chemical reactions and pathways involving CMP-N-acetylneuraminate, a substance composed of 5-(acetylamino)-3,5-dideoxy-D-glycero-D-galacto-non-3-ulosonic acid in glycosidic linkage with cytidine monophosphate. This includes its synthesis from N-acetylneuraminate and CMP, its further enzymatic modification, and its consumption as a donor substrate by sialyltransferases.
Why Is CMP-N-acetylneuraminate metabolic process Important in Cell Biology?
GO:0046381 is important because CMP-N-acetylneuraminate is the committed activated donor for all sialyltransferase reactions, so the pathway sets the ceiling for sialylation of glycoproteins and glycolipids. Sialylation affects mucus barrier function and intestinal host-commensal homeostasis, meaning the pathway influences how the host interacts with its microbiota. In vertebrates, CMP-N-acetylneuraminate is consumed by ST8Sia enzymes to generate polysialic acid, a modification that modulates cell adhesion and can protect against infection by Trypanosoma cruzi. The pathway also intersects with tumor-associated antigen biology, since sialylated antigens such as sTn depend on sialyltransferase activity that uses CMP-N-acetylneuraminate. Finally, enzymatic modification of CMP-N-acetylneuraminate itself, such as hydroxylation in mouse liver, shows that the pathway is not a single linear step but a regulated metabolic node.
• Provides the activated sialic acid donor required by sialyltransferases for glycoprotein and glycolipid sialylation.
• Controls mucus sialylation, which determines intestinal host-commensal homeostasis.
• Supplies substrate for vertebrate alpha2,8-sialyltransferases (ST8Sia) that synthesize polysialic acid.
• Modulates susceptibility to infection, as shown for ST8Sia2-dependent protection against Trypanosoma cruzi.
• Contributes to expression of sialylated tumor-associated antigens such as sTn antigen.
• Is subject to further enzymatic modification, e.g. CMP-N-acetylneuraminate hydroxylase in mouse liver.
• Is conserved in bacteria, as demonstrated by structural and functional characterization of the Vibrio cholerae synthetase.
• Can be studied in diverse systems including human cervical epithelium sialyltransferase assays.
• Represents a metabolic node linking nucleotide-sugar metabolism to cell-surface recognition and signaling.
• Offers a target for glycobiology research and for engineering sialylation in cell models.
What Happens During CMP-N-acetylneuraminate metabolic process?
Synthesis of CMP-N-acetylneuraminate by CMP-N-acetylneuraminate synthetase
In simple terms: First, the cell attaches sialic acid to a carrier molecule called CMP to make the activated donor.
The central activation step of GO:0046381 is the formation of CMP-N-acetylneuraminate from N-acetylneuraminate and CMP, catalyzed by CMP-N-acetylneuraminate synthetase. The enzyme from Vibrio cholerae has been structurally and functionally characterized, providing a model for the catalytic mechanism and substrate recognition of this conserved reaction. This step converts a free sugar into a high-energy nucleotide-sugar donor suitable for transfer reactions.
Modification of CMP-N-acetylneuraminate by hydroxylase and monooxygenase activities
In simple terms: The activated donor can be chemically tweaked before use, changing the type of sialic acid it carries.
CMP-N-acetylneuraminate is not always used directly; it can be further modified. In mouse liver, CMP-N-acetylneuraminate hydroxylase was purified, characterized, and reconstituted, showing that the N-acyl group of the donor can be hydroxylated. In the starfish Asterias rubens, CMP-N-acetylneuraminate monooxygenase activity was detected alongside sialo-oligomers, indicating that modification of the donor occurs in invertebrates as well. These reactions expand the chemical diversity of sialic acids available for downstream transfer.
Utilization by sialyltransferases for glycoconjugate sialylation
In simple terms: Next, enzymes called sialyltransferases take sialic acid from the donor and attach it to sugars on proteins or lipids.
The major fate of CMP-N-acetylneuraminate is its use as a donor substrate by sialyltransferases. A CMP-N-acetylneuraminate:galactosyl-glycoprotein sialyltransferase was characterized from human cervical epithelium, demonstrating direct consumption of the donor for sialylation of glycoprotein acceptors. This transfer reaction is the point at which the activated sugar enters the glycan biosynthetic machinery.
Polysialic acid synthesis by alpha2,8-sialyltransferases
In simple terms: Some sialyltransferases string many sialic acids together into long chains called polysialic acid.
In vertebrates, alpha2,8-sialyltransferases (ST8Sia family) use CMP-N-acetylneuraminate to build alpha2,8-linked polysialic acid on acceptor glycans. ST8Sia2 polysialyltransferase activity has been shown to protect against infection by Trypanosoma cruzi, linking this branch of GO:0046381 to host defense. The teleost perspective on ST8Sia enzymes further illustrates the evolutionary diversification of these CMP-N-acetylneuraminate-consuming enzymes.
Impact on mucus sialylation and host-commensal homeostasis
In simple terms: The sialic acid added using this donor changes mucus, which affects which microbes live in the gut.
Sialylation reactions that depend on CMP-N-acetylneuraminate shape the intestinal mucus layer. Mucus sialylation determines intestinal host-commensal homeostasis, meaning the output of GO:0046381 influences the composition and behavior of the gut microbiota. This connects the pathway to mucosal immunity and microbial ecology.
Contribution to tumor-associated antigen expression
In simple terms: When sialylation goes wrong, cells can display abnormal sugar antigens seen in cancer.
Sialylated tumor-associated antigens such as the sTn antigen depend on sialyltransferase activity that consumes CMP-N-acetylneuraminate. Therefore, the flux through GO:0046381 can influence the display of glycan antigens recognized in cancer biology and immunotherapy research.
Key Genes Involved in GO:0046381 CMP-N-acetylneuraminate metabolic process
The following genes and proteins are experimentally linked to CMP-N-acetylneuraminate metabolism, either by producing, modifying, or consuming the activated donor.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CMP-N-acetylneuraminate synthetase (Vibrio cholerae) | Synthesizes CMP-N-acetylneuraminate from N-acetylneuraminate and CMP | Structurally and functionally characterized enzyme providing a model for the activation step |
| ST8Sia family (vertebrate alpha2,8-sialyltransferases) | Use CMP-N-acetylneuraminate to synthesize alpha2,8-linked polysialic acid | Studied in teleosts and other vertebrates for evolutionary and functional diversity |
| ST8Sia2 | Polysialyltransferase that consumes CMP-N-acetylneuraminate | Protects against Trypanosoma cruzi infection in experimental models |
| CMP-N-acetylneuraminate:galactosyl-glycoprotein sialyltransferase | Transfers sialic acid from CMP-N-acetylneuraminate to glycoprotein acceptors | Characterized in human cervical epithelium |
| CMP-N-acetylneuraminate hydroxylase (mouse liver) | Modifies the N-acyl group of CMP-N-acetylneuraminate | Purified, characterized, and reconstituted, showing donor modification |
| CMP-N-acetylneuraminate monooxygenase (starfish) | Modifies CMP-N-acetylneuraminate in invertebrates | Detected in Asterias rubens alongside sialo-oligomers |
| Sialyltransferases (general) | Consume CMP-N-acetylneuraminate to sialylate glycoconjugates | Central to sialylation pathways and tumor antigen expression |
| Mucus sialylation machinery | Uses CMP-N-acetylneuraminate-derived sialic acid in mucus | Determines intestinal host-commensal homeostasis |
| ST8Sia enzymes (teleost) | Alpha2,8-sialyltransferases using CMP-N-acetylneuraminate | Provide a teleost perspective on vertebrate ST8Sia evolution |
| Sialo-oligomer biosynthetic enzymes (starfish) | Produce sialo-oligomers from CMP-N-acetylneuraminate | Demonstrate invertebrate sialic acid biosynthesis |
| Glycoprotein sialylation enzymes (human cervical epithelium) | Sialylate galactosyl-glycoproteins | Experimental model for CMP-N-acetylneuraminate utilization |
| Tn/sTn antigen-related sialyltransferases | Generate sialylated tumor-associated antigens | Relevant to cancer glycan biomarker research |
| CMP-N-acetylneuraminate synthetase (bacterial homologs) | Activate sialic acid in bacteria | Comparative enzymology and structural studies |
| N-acylneuraminate 8-O-methyltransferase (starfish) | Modifies neuraminate derivatives | Detected in Asterias rubens sialic acid biosynthesis |
| CMP-N-acetylneuraminate hydroxylase cofactors | Support hydroxylation of the donor | Reconstitution studies define cofactor requirements |
| Polysialic acid acceptors (e.g. NCAM) | Accept polysialic acid from ST8Sia enzymes | Model system for CMP-N-acetylneuraminate consumption |
| Intestinal mucus glycoproteins | Carry sialic acid derived from CMP-N-acetylneuraminate | Link pathway to host-microbe homeostasis |
| Sialyltransferase acceptor glycans | Receive sialic acid from CMP-N-acetylneuraminate | Biochemical assays define substrate specificity |
How Is CMP-N-acetylneuraminate metabolic process Regulated?
The CMP-N-acetylneuraminate metabolic process is regulated at multiple levels. The activation step is controlled by the expression and activity of CMP-N-acetylneuraminate synthetase, whose bacterial homolog has been structurally characterized to reveal substrate-binding determinants. The donor can be further modified by hydroxylase and monooxygenase activities, as shown in mouse liver and starfish, which changes the chemical identity of the sialic acid transferred. Consumption of CMP-N-acetylneuraminate is regulated by the expression and specificity of sialyltransferases, including the ST8Sia family in vertebrates. In the intestine, mucus sialylation is a regulated feature that determines host-commensal homeostasis, implying that the pathway responds to microbial and environmental cues. Finally, sialyltransferase activity that uses CMP-N-acetylneuraminate influences tumor-associated antigen expression, suggesting regulation in cancer contexts.
CMP-N-acetylneuraminate metabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ST8Sia2 | Protection against Trypanosoma cruzi infection | Knockout or overexpression in host cells followed by infection assays |
| Mucus sialylation machinery | Intestinal host-commensal homeostasis | Germ-free or gnotobiotic mouse models with mucus sialylation perturbation |
| Sialyltransferases generating sTn | Tumor-associated antigen expression in cancer | Cancer cell lines with knockout or knock-in of sialyltransferase genes |
| CMP-N-acetylneuraminate hydroxylase | Modification of sialic acid donor pool | Reconstitution assays and mouse liver models |
| CMP-N-acetylneuraminate synthetase | Bacterial sialic acid activation | Enzyme assays and structural studies using Vibrio cholerae enzyme |
Infection and host-pathogen interactions
CMP-N-acetylneuraminate metabolism affects infection outcomes. ST8Sia2 polysialyltransferase, which consumes CMP-N-acetylneuraminate, protects against infection by Trypanosoma cruzi. In addition, mucus sialylation determines intestinal host-commensal homeostasis, linking the pathway to microbial colonization and mucosal defense. These findings position GO:0046381 as a determinant of host-microbe interaction.
Cancer and tumor-associated antigens
Sialylated tumor-associated antigens such as the sTn antigen depend on sialyltransferase reactions that use CMP-N-acetylneuraminate. Therefore, altered flux through GO:0046381 can contribute to the glycan signatures observed in cancer. Research on Tn, sTn, and T antigens highlights the importance of sialylation in tumor biology.
Intestinal and mucosal homeostasis
Mucus sialylation, which depends on CMP-N-acetylneuraminate as a donor, determines intestinal host-commensal homeostasis. Disruption of this process could alter the mucus barrier and microbial composition. This makes GO:0046381 relevant to inflammatory and metabolic conditions of the gut, although specific disease associations require further study.
Invertebrate and comparative biology
CMP-N-acetylneuraminate metabolic activities are not restricted to mammals. In the starfish Asterias rubens, sialo-oligomers and CMP-N-acetylneuraminate monooxygenase activity were identified, showing that the pathway operates in invertebrates. Such comparative findings help define conserved versus lineage-specific features of sialic acid metabolism.
From CMP-N-acetylneuraminate metabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a sialyltransferase alter CMP-N-acetylneuraminate consumption? | CRISPR knockout cell line with glycan analysis |
| Does a point mutation in CMP-N-acetylneuraminate synthetase affect catalysis? | Point-mutation knock-in cell model based on structurally characterized enzyme |
| Can tagged CMP-N-acetylneuraminate enzymes be localized in cells? | Tagged knock-in of the synthetase or sialyltransferase |
| Does overexpression of ST8Sia2 change infection outcome? | Overexpression cell model followed by Trypanosoma cruzi infection |
| Does altered mucus sialylation change commensal homeostasis? | In vivo model with perturbed sialylation |
| Does hydroxylase activity modify the donor pool? | Reconstitution and knockout models for CMP-N-acetylneuraminate hydroxylase |
How to Study the CMP-N-acetylneuraminate metabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Sialyltransferase activity assay | Transfer of sialic acid from CMP-N-acetylneuraminate to acceptors | Characterizing enzymes from human cervical epithelium |
| CMP-N-acetylneuraminate synthetase assay | Formation of CMP-N-acetylneuraminate | Functional study of bacterial synthetase |
| Hydroxylase reconstitution assay | Modification of the N-acyl group of the donor | Mouse liver enzyme characterization |
| Sialo-oligomer analysis | Presence and structure of sialylated oligomers | Starfish sialic acid biosynthesis studies |
| Infection assay | Pathogen survival or host cell protection | Trypanosoma cruzi infection with ST8Sia2 |
| Mucus sialylation analysis | Sialic acid content of mucus | Intestinal host-commensal homeostasis studies |
| Tumor antigen detection | Expression of sTn and related antigens | Cancer glycan biomarker research |
| Structural biology (crystallography) | Three-dimensional structure of pathway enzymes | Vibrio cholerae CMP-N-acetylneuraminate synthetase |
Glycan and sialic acid analysis
Biochemical characterization of sialo-oligomers and sialylated glycoconjugates is used to measure the output of CMP-N-acetylneuraminate metabolism. In starfish, sialo-oligomers were identified and enzyme activities detected, providing a template for analyzing sialic acid diversity. Human cervical epithelium sialyltransferase assays demonstrate direct measurement of donor utilization.
Enzyme activity assays
CMP-N-acetylneuraminate synthetase, hydroxylase, and sialyltransferase activities can be measured using purified or reconstituted enzymes. The mouse liver CMP-N-acetylneuraminate hydroxylase was purified, characterized, and reconstituted, illustrating how activity assays define cofactor requirements and kinetics. Bacterial synthetase characterization similarly relies on functional assays.
Structural biology
Structural characterization of CMP-N-acetylneuraminate synthetase from Vibrio cholerae revealed the architecture of the activation step. Such structural data guide mutational analysis and inhibitor design for the pathway.
Infection and host-interaction models
Infection assays using Trypanosoma cruzi test the functional impact of ST8Sia2 and polysialic acid. Intestinal models assess how mucus sialylation affects host-commensal homeostasis. These approaches connect molecular sialylation to organism-level phenotypes.
How CRISPR Can Be Used to Study GO:0046381 CMP-N-acetylneuraminate metabolic process
Knockout
CRISPR knockout of sialyltransferase genes or CMP-N-acetylneuraminate synthetase can eliminate specific branches of GO:0046381, allowing researchers to measure changes in sialylation and downstream phenotypes. For example, knocking out ST8Sia2 would test its role in polysialic acid synthesis and infection protection. Knockout of mucus sialylation machinery could reveal effects on host-commensal homeostasis.
Point Mutation
Point mutations can be introduced into CMP-N-acetylneuraminate synthetase or sialyltransferases to dissect catalytic residues identified by structural studies. Such models help distinguish catalytic activity from protein stability or localization effects. Mutations in hydroxylase domains could similarly probe donor modification.
Knock-in
Knock-in of tagged versions of CMP-N-acetylneuraminate enzymes enables localization and interaction studies. Tagged sialyltransferases can be used to track their distribution and substrate access in cells. Knock-in of disease-associated or species-specific variants can model evolutionary differences, such as those seen in teleost ST8Sia enzymes.
Overexpression
Overexpression of ST8Sia2 or other sialyltransferases increases consumption of CMP-N-acetylneuraminate and can enhance polysialic acid production. This approach was used to show protection against Trypanosoma cruzi infection. Overexpression of synthetase or hydroxylase can also expand the donor pool for glycan engineering.
How EDITGENE Supports CMP-N-acetylneuraminate metabolic process Research
Researchers studying CMP-N-acetylneuraminate metabolic process-related genes often need to determine whether a candidate gene is causally involved in sialylation, infection, or glycan antigen presentation. EDITGENE provides CRISPR-based cell models and screening services to test such hypotheses directly in relevant cell types.
Contact EDITGENE today to design your custom CRISPR model for CMP-N-acetylneuraminate metabolic process research.
Frequently Asked Questions About CMP-N-acetylneuraminate metabolic process
What is CMP-N-acetylneuraminate metabolic process?
It is the biological process (GO:0046381) comprising the chemical reactions and pathways involving CMP-N-acetylneuraminate, the activated sialic acid donor used by sialyltransferases.
What genes are involved in CMP-N-acetylneuraminate metabolic process?
Genes include CMP-N-acetylneuraminate synthetase, sialyltransferases such as ST8Sia family members, and enzymes that modify the donor such as CMP-N-acetylneuraminate hydroxylase.
What is the function of CMP-N-acetylneuraminate?
It serves as the donor substrate for sialyltransferases, which transfer sialic acid to glycoproteins and glycolipids.
How is CMP-N-acetylneuraminate synthesized?
It is synthesized by CMP-N-acetylneuraminate synthetase, which couples N-acetylneuraminate to CMP; the Vibrio cholerae enzyme has been structurally characterized.
Which enzymes use CMP-N-acetylneuraminate?
Sialyltransferases, including alpha2,8-sialyltransferases (ST8Sia family), use CMP-N-acetylneuraminate to sialylate acceptors.
Why is CMP-N-acetylneuraminate metabolism important for infection?
ST8Sia2 polysialyltransferase, which consumes CMP-N-acetylneuraminate, protects against Trypanosoma cruzi infection, and mucus sialylation affects host-commensal homeostasis.
How does CMP-N-acetylneuraminate metabolism relate to cancer?
Sialylated tumor-associated antigens such as sTn depend on sialyltransferase reactions that use CMP-N-acetylneuraminate.
Can CMP-N-acetylneuraminate be modified?
Yes, CMP-N-acetylneuraminate hydroxylase and monooxygenase activities can modify the N-acyl group, as shown in mouse liver and starfish.
What model systems are used to study CMP-N-acetylneuraminate metabolism?
Models include human cervical epithelium sialyltransferase assays, mouse liver enzyme reconstitution, starfish sialic acid analysis, and infection models with ST8Sia2.
How can CRISPR help study CMP-N-acetylneuraminate metabolic process?
CRISPR knockout, point mutation, knock-in, and overexpression can test the causal roles of synthetases, sialyltransferases, and modifying enzymes in sialylation and related phenotypes.
Conclusion
GO:0046381, CMP-N-acetylneuraminate metabolic process, is a central node in sialic acid biology. It produces and modifies the activated donor that sialyltransferases use to sialylate glycoproteins and glycolipids, influencing infection, intestinal homeostasis, and tumor antigen expression. The pathway is conserved from bacteria to vertebrates, with structurally characterized enzymes and diverse downstream consumers. Studying it with CRISPR models and biochemical assays will continue to reveal how sialylation shapes cell and organism biology.
References
- 1. Yao Y et al.. 2022. Mucus sialylation determines intestinal host-commensal homeostasis.. Cell 185(7):1172-1188.e28 PMID: 35303419
- 2. Bose S et al.. 2019. Structural and functional characterization of CMP-N-acetylneuraminate synthetase from Vibrio cholerae.. Acta Crystallogr D Struct Biol 75(Pt 6):564-577 PMID: 31205019
- 3. Tindara Venuto M et al.. 2020. Vertebrate Alpha2,8-Sialyltransferases (ST8Sia): A Teleost Perspective.. Int J Mol Sci 21(2) PMID: 31947579
- 4. Bergwerff AA et al.. 1992. Nature and biosynthesis of sialic acids in the starfish Asterias rubens. Identification of sialo-oligomers and detection of S-adenosyl-L-methionine: N-acylneuraminate 8-O-methyltransferase and CMP-N-acetylneuraminate monooxygenase activities.. Biochimie 74(1):25-37 PMID: 1576206
- 5. Barboza BR et al.. 2024. ST8Sia2 polysialyltransferase protects against infection by Trypanosoma cruzi.. PLoS Negl Trop Dis 18(9):e0012454 PMID: 39321148
- 6. Scudder PR et al.. 1981. Glycosyltransferases of the human cervical epithelium. II. Characterization of a CMP-N-acetylneuraminate: galactosyl-glycoprotein sialyltransferase.. Biochim Biophys Acta 660(1):136-41 PMID: 6168292
- 7. Fu C et al.. 2016. Tumor-associated antigens: Tn antigen, sTn antigen, and T antigen.. HLA 88(6):275-286 PMID: 27679419
- 8. Schneckenburger P et al.. 1994. Purification, characterization and reconstitution of CMP-N-acetylneuraminate hydroxylase from mouse liver.. Glycoconj J 11(3):194-203 PMID: 7841794
